questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines de liaison à l'ADN
Protéines MutS
Protéines MutS : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines MutS : Questions médicales les plus fréquentes",
"headline": "Protéines MutS : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines MutS : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-25",
"dateModified": "2025-03-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines MutS"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de liaison à l'ADN",
"url": "https://questionsmedicales.fr/mesh/D004268",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de liaison à l'ADN",
"code": {
"@type": "MedicalCode",
"code": "D004268",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.260"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine MutS de liaison aux mésappariements de l'ADN",
"alternateName": "MutS DNA Mismatch-Binding Protein",
"url": "https://questionsmedicales.fr/mesh/D051719",
"about": {
"@type": "MedicalCondition",
"name": "Protéine MutS de liaison aux mésappariements de l'ADN",
"code": {
"@type": "MedicalCode",
"code": "D051719",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.260.556.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-3 homologue de MutS",
"alternateName": "MutS Homolog 3 Protein",
"url": "https://questionsmedicales.fr/mesh/D000074081",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-3 homologue de MutS",
"code": {
"@type": "MedicalCode",
"code": "D000074081",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.260.556.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines MutS",
"alternateName": "MutS Proteins",
"code": {
"@type": "MedicalCode",
"code": "D000074080",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Taiki Futagami",
"url": "https://questionsmedicales.fr/author/Taiki%20Futagami",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan. Electronic address: futagami@agri.kagoshima-u.ac.jp."
}
},
{
"@type": "Person",
"name": "Kayu Okutsu",
"url": "https://questionsmedicales.fr/author/Kayu%20Okutsu",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan."
}
},
{
"@type": "Person",
"name": "Yumiko Yoshizaki",
"url": "https://questionsmedicales.fr/author/Yumiko%20Yoshizaki",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan."
}
},
{
"@type": "Person",
"name": "Kazunori Takamine",
"url": "https://questionsmedicales.fr/author/Kazunori%20Takamine",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan."
}
},
{
"@type": "Person",
"name": "Hisanori Tamaki",
"url": "https://questionsmedicales.fr/author/Hisanori%20Tamaki",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Increase in veterinary prescriptions of azithromycin during the COVID-19 pandemic in Brazil.",
"datePublished": "2023-07-27",
"url": "https://questionsmedicales.fr/article/37515794",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3855/jidc.17597"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial.",
"datePublished": "2023-03-27",
"url": "https://questionsmedicales.fr/article/36972694",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4269/ajtmh.22-0763"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of azithromycin in treating Ureaplasma urealyticum: a systematic review and meta-analysis.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36927441",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-023-08102-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39469425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/jpps.2024.13635"
}
},
{
"@type": "ScholarlyArticle",
"name": "Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin.",
"datePublished": "2022-10-05",
"url": "https://questionsmedicales.fr/article/36165496",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09546634.2022.2129953"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de liaison à l'ADN",
"item": "https://questionsmedicales.fr/mesh/D004268"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines MutS",
"item": "https://questionsmedicales.fr/mesh/D000074080"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines MutS - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines MutS",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines MutS",
"description": "Comment diagnostiquer une déficience en protéines MutS ?\nQuels tests sont utilisés pour évaluer l'activité des protéines MutS ?\nLes biopsies peuvent-elles aider au diagnostic ?\nQuels symptômes peuvent indiquer un problème avec MutS ?\nY a-t-il des marqueurs biologiques associés à MutS ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Azithromycin&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines MutS",
"description": "Quels sont les symptômes d'une mutation de MutS ?\nLes symptômes sont-ils toujours présents ?\nComment les symptômes varient-ils selon les individus ?\nLes symptômes peuvent-ils apparaître tardivement ?\nY a-t-il des symptômes associés à d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Azithromycin&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines MutS",
"description": "Comment prévenir les cancers liés à MutS ?\nLes changements de mode de vie aident-ils ?\nLes tests génétiques sont-ils recommandés ?\nY a-t-il des recommandations alimentaires ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Azithromycin&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines MutS",
"description": "Quels traitements sont disponibles pour les cancers liés à MutS ?\nLa thérapie génique est-elle une option ?\nComment la surveillance est-elle effectuée ?\nY a-t-il des traitements préventifs ?\nLes traitements ciblés sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Azithromycin&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines MutS",
"description": "Quelles complications peuvent survenir avec MutS ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des complications psychologiques ?\nLes complications peuvent-elles être prévenues ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Azithromycin&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines MutS",
"description": "Quels sont les principaux facteurs de risque liés à MutS ?\nL'âge est-il un facteur de risque ?\nLe sexe influence-t-il le risque ?\nLes habitudes de vie jouent-elles un rôle ?\nY a-t-il des facteurs environnementaux à considérer ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Azithromycin&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en protéines MutS ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent identifier des mutations dans les gènes codant pour MutS."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des protéines MutS ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de réparation de l'ADN in vitro peuvent mesurer l'activité des protéines MutS."
}
},
{
"@type": "Question",
"name": "Les biopsies peuvent-elles aider au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies tumorales peuvent révéler des anomalies dans les protéines MutS."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec MutS ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes de cancer héréditaire peuvent suggérer une déficience en MutS."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques associés à MutS ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de certains biomarqueurs peuvent indiquer une dysfonction de MutS."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une mutation de MutS ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations peuvent entraîner des cancers, notamment le cancer colorectal héréditaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains individus porteurs de mutations peuvent ne pas présenter de symptômes visibles."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en fonction de l'âge et de l'historique familial."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils apparaître tardivement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cancers liés à MutS peuvent se développer plus tard dans la vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes similaires peuvent être observés dans d'autres syndromes de cancer héréditaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les cancers liés à MutS ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut des dépistages réguliers et des conseils génétiques pour les familles."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de cancer, même avec des mutations."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent aider à identifier les individus à risque élevé."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fibres et en antioxydants est conseillée pour la prévention."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme contre le HPV, peuvent réduire le risque de cancers associés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les cancers liés à MutS ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et l'immunothérapie."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore une option standard pour MutS."
}
},
{
"@type": "Question",
"name": "Comment la surveillance est-elle effectuée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière par des examens endoscopiques est recommandée pour les porteurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions chirurgicales prophylactiques peuvent être envisagées pour réduire le risque."
}
},
{
"@type": "Question",
"name": "Les traitements ciblés sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements ciblés sont en développement et montrent des résultats prometteurs."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec MutS ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent un risque accru de divers cancers et des syndromes associés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en raison des traitements et des symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications psychologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diagnostic de mutations MutS peut entraîner de l'anxiété et du stress."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière et des interventions précoces peuvent aider à prévenir certaines complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque liés à MutS ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de cancer et les mutations génétiques sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de cancer augmente avec l'âge, surtout chez les porteurs de mutations MutS."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mutations peuvent avoir un impact différent selon le sexe, affectant le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie jouent-elles un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie malsaines peuvent augmenter le risque de cancer chez les porteurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains agents cancérigènes peut augmenter le risque chez les porteurs de MutS."
}
}
]
}
]
}
With the advent of the pandemic in 2020 and the lack of perspectives on the treatment of COVID-19, numerous therapeutic proposals have emerged, including hydroxychloroquine and azithromycin. Therefore...
Data on the purchase of antibiotics made under veterinary prescriptions in Brazilian pharmacies between 2014 and 2021 were collected. To assess the changes in monthly trends in the use of the selected...
The most prescribed antibiotic in all years was cephalexin (35%), followed by amoxicillin (24%). During the pandemic, sales of azithromycin substantially increased. Regression analysis showed that sin...
During the pandemic, there was no animal health situation in Brazil that required the use of this antibiotic. Veterinary prescriptions may have been an instrument for human access to azithromycin for ...
Observational studies have linked early-life antibiotic exposure to increased risk of obesity in children in high income settings. We evaluated whether neonatal antibiotic exposure led to changes in i...
Ureaplasma urealyticum is the most prevalent genital mycoplasma isolated from the urogenital tract of females, but there is no unified treatment plan. This study aimed to evaluate the efficacy of azit...
From the earliest to June 2022, published randomized controlled trials (RCTs) on azithromycin treatment of Ureaplasma urealyticum were retrieved by searching PubMed, Embase, Cochrane Library, and Web ...
Seven RCTs were finally included, involving 512 participants (240 in the experimental group, 272 in the control group). The experimental group was treated with azithromycin monotherapy, while the cont...
Regarding the meta-analysis that we performed based on existing clinical studies, azithromycin is quite effective in treating Ureaplasma urealyticum....
The COVID-19 pandemic has raised concern regarding respiratory system diseases and oral inhalation stands out as an attractive non-invasive route of administration for pulmonary diseases such as chron...
Papulopustular rosacea is notoriously a challenge to treat, and treatment options are scarce. Only limited data exist on the use of azithromycin in treatment of papulopustular rosacea. However, the un...
Cancer patients are prescribed antibiotics, such as macrolides and lactamides, for infection treatment. However, the effect of these antibiotics on NLRP3 activation remains largely unknown....
Lung cancer (A549) and prostate cancer (PC3) cell lines were primed with lipopolysaccharide (LPS) to activate NLRP3 transcription. Cells were then treated with azithromycin (Az) or ceftriaxone (Cf). N...
LPS-Az activated transcription of...
Our data suggest that Cf could suppress LPS induced NLRP3, which should be considered when selecting antibiotics for cancer treatment. In contrast, the effect of Az on LPS primed NLRP3 and the inflamm...
The presence of azithromycin in the human plasma of pediatric patients was determined with a UHPLC-MS/MS assay. Sample preparation was done by protein precipitation, and the separation was achieved on...
Bacterial sexually transmitted infections (STIs) pose a major public health problem. The emergence of antibiotic-resistant strains of Neisseria gonorrhoeae represents a serious threat to successful tr...
To identify molecular mechanisms implicated in azithromycin resistance in strains isolated from patients over a three-year period in a university hospital in Switzerland....
From January 2020 to December 2022, 34 isolates (one per patient) were recovered from samples analyzed at the University Hospital of Lausanne. Eight genes involved in azithromycin resistance were sequ...
With a cutoff value of 1 mg/L, 15 isolates were considered as being resistant to azithromycin, whereas the remaining 19 were susceptible. The C2597T mutation in 3 or 4 of the rrl allele confer a mediu...
Resistance to azithromycin was explained by the presence of mutations in many different copies of 23S RNA ribosomal genes and their regulatory genes. Other mutations, previously reported to be associa...
Tobramycin inhalation solution (TIS) and chronic azithromycin (AZ) have known clinical benefits for children with CF, likely due to antimicrobial and anti-inflammatory activity. The effects of chronic...
Substantial changes in bacterial communities (total bacterial load, diversity and relative abundance of specific taxa) were observed by week 3 of TIS treatment for both the AZ and placebo groups. On a...
This study provides further evidence that the mechanism for AZ's effect on clinical outcomes is not due solely to action on airway microbial composition....
The effects of azithromycin mass drug administration (MDA) on trachoma and yaws have been addressed. However, the secondary effects of azithromycin MDA remain unclear. This study aimed to explore the ...